Cliff Asness’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $295M | Sell |
546,002
-280,224
| -34% | -$158M | 0.1% | 272 |
|
|
2026
Q1 | $486M | Sell |
826,226
-455,473
| -36% | -$227M | 0.22% | 93 |
|
|
2025
Q4 | $625M | Buy |
1,281,699
+295,221
| +30% | +$137M | 0.33% | 51 |
|
|
2025
Q3 | $414M | Sell |
986,478
-286,683
| -23% | -$96.4M | 0.27% | 69 |
|
|
2025
Q2 | $363M | Buy |
1,273,161
+364,713
| +40% | +$109M | 0.3% | 60 |
|
|
2025
Q1 | $273M | Sell |
908,448
-66,996
| -7% | -$23M | 0.28% | 71 |
|
|
2024
Q4 | $344M | Buy |
975,444
+7,710
| +0.8% | +$2.83M | 0.44% | 25 |
|
|
2024
Q3 | $347M | Buy |
967,734
+248,224
| +34% | +$83.8M | 0.48% | 23 |
|
|
2024
Q2 | $229M | Sell |
719,510
-127,445
| -15% | -$33.7M | 0.35% | 51 |
|
|
2024
Q1 | $195M | Buy |
846,955
+295,188
| +53% | +$66.6M | 0.33% | 65 |
|
|
2023
Q4 | $121M | Buy |
551,767
+75,179
| +16% | +$17.3M | 0.23% | 99 |
|
|
2023
Q3 | $108M | Sell |
476,588
-34,013
| -7% | -$7.83M | 0.22% | 101 |
|
|
2023
Q2 | $112M | Buy |
510,601
+137,378
| +37% | +$30.4M | 0.24% | 95 |
|
|
2023
Q1 | $82.4M | Buy |
373,223
+113,214
| +44% | +$27.9M | 0.18% | 131 |
|
|
2022
Q4 | $71.3M | Sell |
260,009
-34,079
| -12% | -$8.6M | 0.16% | 153 |
|
|
2022
Q3 | $61.3M | Sell |
294,088
-58,990
| -17% | -$13.2M | 0.15% | 164 |
|
|
2022
Q2 | $83.2M | Sell |
353,078
-23,313
| -6% | -$4.74M | 0.19% | 132 |
|
|
2022
Q1 | $66.1M | Sell |
376,391
-25,645
| -6% | -$4.89M | 0.13% | 195 |
|
|
2021
Q4 | $86.9M | Sell |
402,036
-49,571
| -11% | -$9.73M | 0.16% | 148 |
|
|
2021
Q3 | $83.4M | Sell |
451,607
-55,171
| -11% | -$10.9M | 0.15% | 160 |
|
|
2021
Q2 | $89.6M | Sell |
506,778
-120,489
| -19% | -$22.9M | 0.16% | 158 |
|
|
2021
Q1 | $105M | Buy |
627,267
+3,071
| +0.5% | +$512K | 0.17% | 136 |
|
|
2020
Q4 | $94.7M | Sell |
624,196
-318,854
| -34% | -$41.8M | 0.17% | 136 |
|
|
2020
Q3 | $95.2M | Buy |
943,050
+11,178
| +1% | +$1.23M | 0.16% | 147 |
|
|
2020
Q2 | $113M | Buy |
931,872
+57,566
| +7% | +$6.48M | 0.18% | 129 |
|
|
2020
Q1 | $82.9M | Buy |
874,306
+203,177
| +30% | +$19.3M | 0.14% | 174 |
|
|
2019
Q4 | $58.6M | Buy |
671,129
+133,916
| +25% | +$11.8M | 0.07% | 356 |
|
|
2019
Q3 | $42.8M | Sell |
537,213
-593,931
| -53% | -$47.8M | 0.05% | 410 |
|
|
2019
Q2 | $87.6M | Sell |
1,131,144
-1,358,074
| -55% | -$127M | 0.1% | 240 |
|
|
2019
Q1 | $292M | Sell |
2,489,218
-25,345
| -1% | -$2.95M | 0.31% | 89 |
|
|
2018
Q4 | $274M | Buy |
2,514,563
+187,196
| +8% | +$21.7M | 0.32% | 82 |
|
|
2018
Q3 | $298M | Buy |
2,327,367
+235,459
| +11% | +$29.1M | 0.28% | 88 |
|
|
2018
Q2 | $237M | Buy |
2,091,908
+269,437
| +15% | +$29.6M | 0.24% | 109 |
|
|
2018
Q1 | $205M | Sell |
1,822,471
-110,571
| -6% | -$14M | 0.22% | 113 |
|
|
2017
Q4 | $286M | Sell |
1,933,042
-246,958
| -11% | -$31.4M | 0.3% | 85 |
|
|
2017
Q3 | $258M | Sell |
2,180,000
-9,201
| -0.4% | -$1.18M | 0.31% | 83 |
|
|
2017
Q2 | $284M | Buy |
2,189,201
+452,844
| +26% | +$56.5M | 0.38% | 61 |
|
|
2017
Q1 | $235M | Buy |
1,736,357
+377,395
| +28% | +$57.2M | 0.31% | 77 |
|
|
2016
Q4 | $195M | Sell |
1,358,962
-224,895
| -14% | -$28.7M | 0.27% | 84 |
|
|
2016
Q3 | $187M | Sell |
1,583,857
-256
| -0% | -$30.8K | 0.29% | 76 |
|
|
2016
Q2 | $168M | Buy |
1,584,113
+277,266
| +21% | +$30.9M | 0.3% | 76 |
|
|
2016
Q1 | $146M | Sell |
1,306,847
-481,925
| -27% | -$61M | 0.26% | 100 |
|
|
2015
Q4 | $280M | Buy |
1,788,772
+485,617
| +37% | +$70.7M | 0.49% | 31 |
|
|
2015
Q3 | $171M | Buy |
1,303,155
+446,846
| +52% | +$71.7M | 0.34% | 66 |
|
|
2015
Q2 | $149M | Buy |
856,309
+54,920
| +7% | +$9.88M | 0.3% | 87 |
|
|
2015
Q1 | $138M | Sell |
801,389
-70,166
| -8% | -$10.7M | 0.32% | 83 |
|
|
2014
Q4 | $113M | Buy |
871,555
+322,511
| +59% | +$41.6M | 0.24% | 122 |
|
|
2014
Q3 | $70.6M | Buy |
549,044
+35,200
| +7% | +$3.63M | 0.19% | 141 |
|
|
2014
Q2 | $45.5M | Buy |
513,844
+103,000
| +25% | +$9.91M | 0.12% | 220 |
|
|
2014
Q1 | $38.6M | Buy |
410,844
+143,911
| +54% | +$14.7M | 0.12% | 210 |
|
|
2013
Q4 | $30.2M | Buy |
266,933
+91,449
| +52% | +$8.25M | 0.09% | 275 |
|
|
2013
Q3 | $13.8M | Sell |
175,484
-14,728
| -8% | -$1.08M | 0.05% | 454 |
|
|
2013
Q2 | $12.5M | Buy |
+190,212
| New | +$12.3M | 0.04% | 493 |
|
Other funds holding UTHR
ACA
JT
Cliff Asness's UTHR Position: Q2 2026 in Review
Cliff Asness reduced its United Therapeutics (UTHR) stake by 34% in Q2 2026, selling an estimated $158M and leaving 546,002 shares worth $295M. The position accounts for 0.1% of the portfolio, ranked #272.
Cliff Asness first reported a position in UTHR in Q2 2013 and has held it in 53 quarters since. The position peaked at $625M in Q4 2025. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Cliff Asness held 546,002 shares of United Therapeutics worth $295M as of Q2 2026.
- Cliff Asness sold 280,224 United Therapeutics shares in Q2 2026, an estimated $158M.
- United Therapeutics made up 0.1% of Cliff Asness's portfolio in Q2 2026, its #272 holding.
- Cliff Asness first reported a position in United Therapeutics in Q2 2013 and has held it in 53 quarters since.
- Cliff Asness's United Therapeutics position peaked at $625M in Q4 2025.
- 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.